Life ScienceCompany
GlaxoSmithKline - 25 Pharmaceutical Products Ownership
Who owns GlaxoSmithKline - 25 Pharmaceutical Products?
GlaxoSmithKline - 25 Pharmaceutical Products is owned by Aspen Pharmacare Holdings. It was acquired on August 15, 2012.
GlaxoSmithKline - 25 Pharmaceutical Products Business Overview
Where is GlaxoSmithKline - 25 Pharmaceutical Products headquartered?
GlaxoSmithKline - 25 Pharmaceutical Products is headquartered in Australia.
What sector is GlaxoSmithKline - 25 Pharmaceutical Products in?
GlaxoSmithKline - 25 Pharmaceutical Products is a life science company.
Life Science M&A Summary in 2012
Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.
Join Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.